AN-1792

· Janssen Alzheimer Immunotherapy Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AN-1792, covering 2009-09-24 to 2009-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease [Phase 2]